Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled case series study

Lane JCE., Weaves J., Kostka K., Newby D., Prieto-Alhambra D., Alser O., Prats Uribe A.

DOI

10.1101/2020.04.08.20054551

Type

Preprint

Publication Date

2020-05-31T00:00:00+00:00

Keywords

SARS-CoV-2, rheumatoid arthritis, hydroxychloroquine, azithromycin, covid-19, international, serious adverse event, epidemiology, chloroquine, coronavirus, safety

Permalink More information Close